We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWL:ASXNetwealth Group Ltd. Analysis

Data as of 2026-06-11 - not real-time

A$21.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Netwealth (NWL) trades at AUD 21.32, well below its DCF‑derived fair value of AUD 27.03, implying roughly a 27% upside. Revenue is expanding at a robust 23% YoY and the company enjoys strong gross (66%) and operating (49%) margins, but the current trailing PE of 92.7 is more than double the industry average of 36.5, flagging a valuation disconnect. Dividend sustainability is questionable with a payout ratio exceeding 160%, and the 30‑day volatility of 26.6% combined with a beta near 1 suggests market‑wide risk exposure. Despite a bearish trend on the price chart (20‑day SMA below price, MACD turning bullish), the extreme greed sentiment (86.7) and increasing volume point to growing investor interest. Overall, the stock appears undervalued on intrinsic grounds but carries heightened risk from high valuation multiples and sector dynamics.
Investors should weigh the upside potential against the elevated PE and dividend concerns. The technical picture is mixed: support sits at 20.77, resistance at 22.99, RSI at 41 indicates room for price appreciation, while the MACD histogram has turned positive. Given the strong fundamentals, expanding cash base, and low debt, a cautious buy stance is warranted, especially for medium‑ to long‑term horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near support with upside to DCF fair value
  • Increasing volume indicating buying pressure
  • Technical MACD histogram turning positive

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Undervalued relative to intrinsic DCF estimate
  • Improving cash generation and low leverage

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable business model in a growing wealth‑management market
  • Robust ROE and ROA indicating efficient capital use
  • Long‑term upside from market share gains despite current high PE

Key Metrics & Analysis

Financial Health

Revenue Growth23.80%
Profit Margin15.71%
P/E Ratio92.7
ROE34.57%
ROA41.82%
Debt/Equity8.37
P/B Ratio35.0
Op. Cash FlowA$141.3M
Free Cash FlowA$189.4M
Industry P/E36.5

Technical Analysis

TrendBearish
RSI41.4
SupportA$20.77
ResistanceA$22.99
MA 20A$21.83
MA 50A$22.78
MA 200A$26.22
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair ValueA$27.03
Target PriceA$27.12
Upside/Downside27.20%
GradeUndervalued
TypeGrowth
Dividend Yield1.97%

Risk Assessment

Beta0.96
Volatility26.56%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.